Pharm Final- Chapter 104

A patient with ocular hypertension will begin using brimonidine [Alphagan] for long-term reduction of increased ocular pressure (IOP). The nurse teaches the patient about this medication. Which statement by the patient indicates understanding of the teaching? a. "After using the drops, I should wait 15 minutes before putting in contacts." b. "Because this is a topical medication, drowsiness will not occur." c. "I will not have cardiovascular side effects when using this medication." d. "If my eyes begin to itch or turn red, it means I am allergic to this drug."

a. "After using the drops, I should wait 15 minutes before putting in contacts."

A patient begins using timolol [Timoptic] to treat primary open-angle glaucoma (POAG). The nurse gives a dose and notes that the patient develops shortness of breath. The nurse assesses the patient and auscultates wheezes in both lungs. The nurse will ask this patient about a history of which condition? a. Asthma b. Atrioventricular heart block c. Pulmonary hypertension d. Sinus bradycardia

a. Asthma

An older adult patient comes to an ophthalmology clinic complaining of increased difficulty reading in dim light. The provider examines the patient and notes three large yellow deposits under the patient's cornea. The nurse will expect the provider to order which treatment for this patient? a. High doses of vitamins C and E, beta-carotene, and zinc b. Laser therapy c. Pegaptanib [Macugen] d. Photodynamic therapy

a. High doses of vitamins C and E, beta-carotene, and zinc

A patient has been using latanoprost [Xalatan] ophthalmic drops. The patient tells the nurse, "My eyes used to be greenish-brown, but now they're brown." What will the nurse do? a. Reassure the patient that this is a harmless side effect. b. Report this toxic effect to the patient's provider. c. Tell the patient that this indicates an increased risk of migraine headaches. d. Tell the patient that this effect will reverse when the medication is withdrawn.

a. Reassure the patient that this is a harmless side effect.

A nurse is preparing to administer timolol [Timoptic] eye drops to a patient who has open angle glaucoma. The nurse notes that the patient has a history of chronic obstructive pulmonary disease (COPD). The nurse will contact the provider to discuss changing to which medication? a. betaxolol b. carteolol c. levobunolol d. metipranolol

a. betaxolol

A patient with severe allergic conjunctivitis who has been using cromolyn ophthalmic drops for 2 days calls the nurse to report persistence of the symptoms. When the nurse explains that it takes several weeks for maximum benefit to occur, the patient asks if there is something else to use in the meantime. The nurse will suggest that the patient discuss which drug with the provider? a. An ophthalmic demulcent b. H1-receptor antagonists c. Glucocorticoid drops d. Ocular decongestants

b. H1-receptor antagonists

A nurse is teaching a patient who will begin using a fixed-dose preparation of dorzolamide and timolol [Cosopt] for open-angle glaucoma. Which statement by the patient indicates a need for further teaching? a. "Blurred vision, tearing, or eye dryness may occur with this medication." b. "I may experience a bitter taste in my mouth after instilling these eye drops." c. "I will need to instill two eye drops 3 times daily in each eye." d. "If I notice redness in my eyes or eyelids, I should stop using these drops."

c. "I will need to instill two eye drops 3 times daily in each eye."

A patient has had dilation of the eyes with an anticholinergic agent. What will the nurse say when preparing this patient to go home after the examination? a. "Systemic side effects will not occur with this agent." b. "You may experience an increased heart rate, but this is a harmless side effect." c. "You may need to wear dark glasses until this medication wears off." d. "You will be able to read as soon as the exam is completed."

c. "You may need to wear dark glasses until this medication wears off."

. A nurse administers timolol [Timoptic] ophthalmic drops to a patient who has glaucoma. The patient reports stinging of the eyes shortly after the drops were administered. What will the nurse do? a. Monitor the patient's heart rate, respiratory rate, and blood pressure. b. Notify the provider that the patient shows signs of angle-closure glaucoma. c. Reassure the patient that these are localized, reversible effects of the drug. d. Request an order for an antihistamine to treat this allergic response to the drug.

c. Reassure the patient that these are localized, reversible effects of the drug.

A nursing student asks the nurse to discuss the differences between POAG and angle-closure glaucoma. Which statement by the nurse is correct? a. "Angle-closure glaucoma may be asymptomatic until irreversible damage has occurred." b. "Both types are more common in African American patients." c. "Drug therapy is the definitive treatment for angle-closure glaucoma." d. "Early treatment with prostaglandin analogs can stop the progression of POAG."

d. "Early treatment with prostaglandin analogs can stop the progression of POAG."

A nurse in an ophthalmology clinic instills an anticholinergic agent into a patient's eyes. The nurse provides teaching when the patient asks the reason for the drops. Which statement by the patient indicates a need for further teaching? a. "The drops help prevent my lenses from moving during the exam." b. "The drops will cause me to have blurred vision and sensitivity to light." c. "These drops allow the ophthalmologist to see inside my eyes." d. "This medication anesthetizes my eyes so that the exam won't be painful."

d. "This medication anesthetizes my eyes so that the exam won't be painful."

A nurse is teaching a patient diagnosed with wet ARMD who will begin receiving bevacizumab [Avastin]. Which statement by the patient indicates a need for further teaching? a. "I should be able to improve my visual acuity by using this drug." b. "I should report eye pain and photophobia to my provider if they occur." c. "This drug will help suppress the growth of new blood vessels." d. "This medication will not reduce the risk of blindness."

d. "This medication will not reduce the risk of blindness."